PLoS ONE (Jan 2017)

Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.

  • Ji Yun Noh,
  • Sooyeon Lim,
  • Joon Young Song,
  • Won Suk Choi,
  • Hye Won Jeong,
  • Jung Yeon Heo,
  • Jacob Lee,
  • Yu Bin Seo,
  • Jin-Soo Lee,
  • Seong Heon Wie,
  • Young Keun Kim,
  • Kyung Hwa Park,
  • Sook-In Jung,
  • Shin Woo Kim,
  • Sun Hee Lee,
  • Han Sol Lee,
  • Young Hoon Yoon,
  • Hee Jin Cheong,
  • Woo Joo Kim

DOI
https://doi.org/10.1371/journal.pone.0178010
Journal volume & issue
Vol. 12, no. 5
p. e0178010

Abstract

Read online

In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C.2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.